Form 4 for DH Definitive Healthcare Corp.
Accepted 2024-05-03 00:00:00 ET · period of report 2024-05-01 · accession 0001415889-24-012148 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-05-03 | 2024-05-01 | DH | Moschella William | Chief Product, Tech Off | A - Grant | $0.00 | +297.7K | 496.9K | +149% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-05-01 | A | A | 297,686 | $0.00 | 496,912 | D | — | — | (F1) Represents restricted stock units ("RSUs"), each representing a contingent right to receive one share of the Issuer's Class A Common Stock, par value $0.001, consisting of (i) 154,356 RSUs and (ii) 143,330 RSUs, in each case vesting over a four-year period, with 25% of the RSUs vesting on February 1, 2025, followed by vesting of 6.25% every three months thereafter over the subsequent three years, in each case subject to the Reporting Person's continued service with the Issuer through each such vesting date. |